Jiangsu Hengrui Pharmaceuticals Co Ltd

Return on Assets, %

9.9

-2.7

Net income margin, %

20.5

2.8

EBITDA margin, %

24.2

10.8

Debt to Equity, %

0.8

19.2

Intangible assets and goodwill, %

7.2

3.6

Revenue CAGR 3Y, %

-3

8.5

Total Equity change 1Y, %

-1.1

0

Revenue Y, % chg

0.1

0.5

P/E

66.6

22.7

P/BV

7

1.5

P/S

12.5

2.3

EV/S

11.8

2.4

EV/EBITDA

73.2

7.4

Average Analyst recommendation

Buy

Buy

Average upside forecasts, %

22.4

51.3

Forward P/E

49.6

15.6

Dividend Yield, %

0.3

1.7

Forward Dividend Yield, %

0

0.2

Expected dividend per share

0

0

Payout Ratio, %

34.6

30.3

Dividend Ex Date

2023-06-08